INmune Bio Stock (NASDAQ: INMB) stock price, news, charts, stock research, profile.
You can purchase shares of INmune Bio (NASDAQ:INMB) through any online brokerage.
Other companies in INmune Bio’s space includes: Cabaletta Bio (NASDAQ:CABA), Invizyne Technologies (NASDAQ:IZTC), Anixa Biosciences (NASDAQ:ANIX), Monopar Therapeutics (NASDAQ:MNPR) and Inovio Pharmaceuticals (NASDAQ:INO).
INmune Bio has a consensus price target of $16.17.
The stock price for INmune Bio (NASDAQ: INMB) is $4.76 last updated November 21, 2024 at 4:02 PM EST.
There are no upcoming dividends for INmune Bio.
INmune Bio’s Q3 earnings are confirmed for Thursday, October 31, 2024.
There is no upcoming split for INmune Bio.
INmune Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.